Watchlist Price Alert

Milestone Pharmaceuticals... (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.74

0.02 (1.16%)

At close: Jun 17, 2025, 3:59 PM

1.72

-0.86%

After-hours: Jun 17, 2025, 07:39 PM EDT

Milestone Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	25.31M	13.76M	7.64M	114.14M	72.31M	119.82M	85.95M	10.88M
Short-Term Investments	44.38M	52.24M	56.95M	n/a	70M	n/a	29K	16.03M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-2.68M	-926K	-1.29M	-929K	n/a	n/a
Receivables	2.39M	3.85M	1.21M	483K	948K	836K	677K	543K
Inventory	n/a	n/a	-331K	-356K	-725K	-578K	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	73.93M	73.03M	71.8M	118.92M	148.69M	122.5M	88.05M	27.55M
Property-Plant & Equipment	1.57M	2.19M	2.68M	926K	1.29M	929K	30K	35K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.57M	2.19M	2.68M	926K	1.29M	929K	30K	35K
Total Assets	75.5M	75.23M	74.48M	119.85M	149.97M	123.43M	88.08M	27.59M
Account Payables	1.93M	3.98M	2.26M	4.38M	4.64M	4.38M	2.6M	4K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	571K	n/a	495K	224K	245K	330K	n/a	n/a
Other Current Liabilities	3.12M	1.99M	2.08M	1.23M	71K	1.51M	56K	1.11M
Total Current Liabilities	8.13M	7.23M	6.14M	6.78M	6.16M	8.33M	4.53M	1.6M
Long-Term Debt	53.35M	49.77M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	138.76M	59.1M
Total Long-Term Liabilities	54.23M	51.23M	2M	474K	696K	184K	138.76M	59.1M
Total Liabilities	62.35M	58.45M	8.13M	7.25M	6.86M	8.51M	143.29M	60.71M
Total Debt	54.8M	51.77M	2.49M	698K	941K	514K	n/a	n/a
Common Stock	288.05M	260.5M	273.9M	251.9M	251.68M	226.25M	2.04M	1.23M
Retained Earnings	-367.55M	-326.03M	-266.34M	-206.32M	-163.47M	-113.5M	-58.27M	-35.09M
Comprehensive Income	n/a	48.46M	34.35M	-1.63M	-1.63M	-1.63M	-1.63M	-1.63M
Shareholders Equity	13.15M	16.77M	66.35M	112.6M	143.12M	114.92M	-55.21M	-33.12M
Total Investments	44.38M	52.24M	56.95M	n/a	70M	n/a	29K	16.03M